The pathways most commonly activated in GBM include signaling downstream of receptor tyrosine kinases (RTKs); the PI3K/AKT/mTOR pathway; RAS/MAP/ERK signaling; TGF-B and NF-κB [177]. This evidence concerns the gene MTOR and glioblastoma.